Drug Trial Radar · NCT04830124
Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6
Last checked: Nov 19, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
173
Actual
Start
Sep 27, 2021
Primary completion
May 8, 2025
Study completion May 8, 2025
Sponsor
- Lead sponsor
- Mural Oncology, IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma
Conditions
- Cutaneous Melanoma
- Mucosal Melanoma
Interventions
Nemvaleukin Alfa SubcutaneousDrug
Subcutaneous injection of nemvaleukin every 7 days
Nemvaleukin Alfa IntravenousDrug
Intravenous (IV) infusion over 30 minutes given daily for 5 consecutive days
Nemvaleukin Alfa Intravenous Less Frequent DosingDrug
Intravenous (IV) infusion over 30 minutes twice every 21 days (Day 1 and Day 8 dosing of a 21 day cycle)
PembrolizumabDrug
Cohort 4 only: 200mg IV pembrolizumab on Day 1 of a 21-day cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Centrally-assessed overall response rate (ORR) (Cohort 1 and 2)Time frame: Assessed up to 2 years from the first dose
- Investigator-assessed overall response rate (ORR) (Cohort 3 and 4)Time frame: Assessed up to 2 years from the first dose
Locations
41 sites in 8 countries. Site status is shown where the registry gives one.
UC San Diego Moores Cancer Center
La Jolla, California
The Angeles Clinic and Research Institute
Los Angeles, California
Mayo Clinic
Jacksonville, Florida
Orlando Health, Inc
Orlando, Florida
Norton Cancer Center
Louisville, Kentucky
Massachusetts General Hospital
Boston, Massachusetts
NYU Laura and Isaac Perimutter Cancer Center
New York, New York
Columbia University Medical Center
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
UT Southwestern Medical Center of Dallas
Dallas, Texas
The Queen Elizabeth Hospital
Woodville, Australia
Calvary Mater Newcastle
Waratah, New South Wales, Australia
John Flynn Private Hospital
Tugun, Queensland, Australia
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, Canada
McGill University Health Center (MUHC)
Montreal, Quebec, Canada
Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari
Bari, Italy
Fondazione IRCC Istituto Nazionale dei Tumori
Milan, Italy
Veneto Oncology Institute
Padova, Italy
Ospedale S. Maria della Misericordia
Perugia, Italy
IRCCS Istituti Fisioterapici Ospitalieri
Roma, Italy
Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte
Siena, Italy
Chungnam National University Hospital
Daejeon, South Korea
Kyungpook National University Chilgok Hospital
Daegu, Daegu, South Korea
The Catholic Univ. of Korea, Seoul St. Marys Hospital
Seoul, Seocho-gu, South Korea
Severance Hospital Yonsei University Health System
Seoul, Seodaemun-Gu, South Korea
Samsung Medical Center
Gangam-gu, Seoul, South Korea
Seoul National University Hospital
Jongno-gu, Seoul, South Korea
Asan Medical Center
Songpa-Gu, Seoul, South Korea
Hospital Clinic Barcelona
Barcelona, Spain
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Hospital General Universitario
Madrid, Spain
Hospital Regional de Málaga
Málaga, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
Hospital Universitario Quiron Pozuelo
Madrid, Madrid, Spain
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Chang Gung Memorial Hospital LinKou
Taoyuan, Taiwan
Taipei Veterans General Hospital, VGHTPE
Taipei, Taipei, Taiwan
Royal Marsden Hospital
London, United Kingdom
The Christie Hospital
Manchester, United Kingdom
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.